TG Therapeutics, Inc.

TG Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• TG Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was 34.8 M, a 303.56% increase year-over-year.
• TG Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was 107.6 M, a 15.10% decrease year-over-year.
• TG Therapeutics, Inc. annual operating income for 2025 was 123.3 M, a 194.13% increase from 2024.
• TG Therapeutics, Inc. annual operating income for 2024 was 41.9 M, a 103.21% increase from 2023.
• TG Therapeutics, Inc. annual operating income for 2023 was 20.6 M, a 109.45% decrease from 2022.
• TG Therapeutics, Inc. annual operating income for 2022 was -218.3 M.